TearLab Corp (NASDAQ:TEAR) CEO Elias Vamvakas acquired 30,000 shares of TearLab Corp stock in a transaction dated Tuesday, May 13th. The shares were purchased at an average cost of $3.99 per share, for a total transaction of $119,700.00. Following the transaction, the chief executive officer now directly owns 201,404 shares of the company’s stock, valued at approximately $803,602. TearLab Corp (NASDAQ:TEAR) weekly performance is 20.91%. On last trading day company shares ended up $4.80. Analysts mean target price for the company is $12.00. TearLab Corp (NASDAQ:TEAR) distance from 50-day simple moving average (SMA50) is -17.96%.
MoSys Inc. (NASDAQ:MOSY) a leader in semiconductor solutions that enable fast, intelligent data access for network and communications systems, announced that Len Perham, chief executive officer, and Jim Sullivan, chief financial officer, will participate at The Benchmark Company One-on-One Investor Conference and will be available to meet with investors on Thursday, May 29, 2014 at The Pfister Hotel in Milwaukee, WI. MoSys Inc. (NASDAQ:MOSY) shares advanced 5.83% in last trading session and ended the day on $3.27. Gross Margin is 77.30% and its return on assets is -34.90%. MoSys Inc. (NASDAQ:MOSY) quarterly performance is -30.28%.
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced that it has entered into a Settlement Agreement with Ranbaxy Inc. to dismiss, without prejudice, its patent infringement action pending against Ranbaxy in the United States District Court for the District of Delaware. In the suit, Acura alleges that a generic of Acura’s AVERSION® oxycodone product, previously marketed by Pfizer Inc. under its brand name OXECTA®, for which Ranbaxy is seeking approval to market in the United States pursuant to an Abbreviated New Drug Application (ANDA) filing with the U.S. Food and Drug Administration (FDA) infringes U.S. patents owned by Acura. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) shares moved up 7.96% in last trading session and was closed at $1.22, while trading in range of $1.15 – $1.23. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) year to date (YTD) performance is -26.95%.
American Superconductor Corporation (NASDAQ:AMSC) a global solutions provider serving wind and power grid industry leaders, announced that it has successfully installed and commissioned three D-VAR(R) STATCOM systems in Africa and the United States. The new installations are connecting renewable power plants to the grid and ensuring power quality at industrial sites. Additionally, AMSC announced that it has won four new D-VAR contracts in Australia, North America, and South Africa. For all of these new contracts, the D-VAR system will be used to meet grid interconnection standards and safely and efficiently connect wind and solar energy generation plants to the power grid. American Superconductor Corporation (NASDAQ:AMSC) ended the last trading day at $1.40. Company weekly volatility is calculated as 7.06% and price to cash ratio as 2.69. American Superconductor Corporation (NASDAQ:AMSC) showed a positive weekly performance of 9.38%.
Uranium Energy Corp. (NYSEMKT:UEC) was a big mover last session, as the company saw its shares rise over 21% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $0.99 to $1.15 in the past one-month time frame. Uranium Energy Corp. (NYSEMKT:UEC) weekly performance is 62.63%. On last trading day company shares ended up $1.61. Analysts mean target price for the company is $2.56. Uranium Energy Corp. (NYSEMKT:UEC) distance from 50-day simple moving average (SMA50) is 23.09%.
Leave a Reply